SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-000885
Filing Date
2020-01-13
Accepted
2020-01-13 16:58:44
Documents
77
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-K rasp-20190930.htm   iXBRL 10-K 1954066
7 GRAPHIC imgh4ginez2ivu03141141.jpg GRAPHIC 15253
8 GRAPHIC imgjd4ntjwhzdk03141139.jpg GRAPHIC 33958
9 GRAPHIC imgqimeiwmgfeb03141139.jpg GRAPHIC 33291
10 EXHIBIT 21 ex21_1.htm EX-21 1856
11 EXHIBIT 24 ex24_2.htm EX-24 24757
12 EXHIBIT 31.1 ex311_3.htm EX-31.1 18997
13 EXHIBIT 31.2 ex312_4.htm EX-31.2 18525
14 EXHIBIT 32.1 ex321_5.htm EX-32.1 10943
15 EXHIBIT 32.2 ex322_6.htm EX-32.2 12006
  Complete submission text file 0001213900-20-000885.txt   8200526

Data Files

Seq Description Document Type Size
2 SCHEMA rasp-20190930.xsd EX-101.SCH 57598
3 CALCULATION rasp-20190930_cal.xml EX-101.CAL 77963
4 DEFINITION rasp-20190930_def.xml EX-101.DEF 273252
5 LABEL rasp-20190930_lab.xml EX-101.LAB 946449
6 PRESENTATION rasp-20190930_pre.xml EX-101.PRE 486096
39 EXTRACTED XBRL INSTANCE DOCUMENT rasp-20190930_htm.xml XML 1128026
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191083 | Film No.: 20524244
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences